24 - 25 NOVEMBER 2025
A hands-on cadaveric course for safer aesthetic practice
This intensive two-day program combines cadaver-based anatomy training, live expert demonstrations, and complication management strategies to equip aesthetic practitioners with the knowledge and skills required for safer, more effective practice.
Led by internationally recognized faculty, the course integrates anatomical dissection, advanced injection techniques, and real-world complication management into a structured learning experience.
This program is open in Greece exclusively to certified Dermatologists and Plastic Surgeons. Internationally, it welcomes licensed Healthcare Professionals from all specialties practicing aesthetics.
Dr. Maurizio Cavallini is an internationally recognized plastic surgeon based in Milan, Italy, with
over 30 years of experience in reconstructive and aesthetic surgery. A graduate with highest
honors from the University of Milan, he specialized in Plastic and Reconstructive Surgery,
Microsurgery, and Experimental Surgery. He is currently Head of the Dermatologic and Plastic
Surgery Unit at the Centro Diagnostico Italiano in Milan and lectures at the Universities of Milan,
Genoa, and Modena. Author of more than 130 scientific publications and textbooks, Dr. Cavallini
has also served since 2024 as President of the Italian Society of Aesthetic Medicine (Agorà).
DIMITRIOS SYKIANAKIS, AESTHETIC EXPERT, GREECE
Dr. Dimitris Sykianakis is an internationally recognized Anti-Aging and Aesthetic Medicine doctor
and trainer with over 25 years of experience. He has performed more than 70,000 injectable
treatments and is widely respected for his role as an international KOL with the Allergan Medical
Institute, where he has trained hundreds of practitioners across more than 15 countries. A
frequent speaker at international congresses and symposia, he is known for advancing
innovative injection techniques and encouraging peer-to-peer knowledge exchange. Since 2018,
Dr. Sykianakis has been part of the selective MdM program and holds a PhD in
OnabotulinumtoxinA.